Bristol-Myers to sell Abilify in U.S. until 2015
April 06, 2009 at 10:04 AM EDT
Bristol-Myers Squibb says Monday that it has reached a deal with Japanese firm Otsuka Pharmaceutical Co. that will allow it to sell the popular antidepressant Abilify in the U.S. until 2015.
